产前叶黄素或玉米黄质补充改善Bco2-/-黄斑色素小鼠的氧诱导视网膜病变
研究利用Bco2-/-黄斑色素小鼠的氧诱导视网膜病变(OIR)模型,按补充类型(叶黄素、玉米黄质或安慰剂)和产前补充起始时间(E0、E11、P1)分为九个亚组。结果显示,产前补充叶黄素或玉米黄质显著减少血管无灌注区和玻璃体内新生血管面积,且E0或E11起始补充较P1产后补充保护作用更强。作者建议未来在人类临床试验中测试产前叶黄素和玉米黄质补充以预防早产儿视网膜病变(ROP)。
要点
- 产前补充叶黄素或玉米黄质显著减少OIR小鼠血管无灌注区和玻璃体内新生血管面积。
- E0或E11起始的产前补充对OIR的保护作用显著优于P1起始的产后补充。
- 作者建议未来在人类临床试验中测试产前叶黄素和玉米黄质补充以预防ROP。
核心结论
- 产前补充叶黄素和玉米黄质在小鼠OIR模型中具有保护作用。
- 作者建议未来在人类临床试验中测试产前叶黄素和玉米黄质补充以预防ROP。
研究设计与样本
- 研究采用Bco2-/-黄斑色素小鼠的氧诱导视网膜病变(OIR)模型。
- 孕鼠按补充类型(叶黄素、玉米黄质或安慰剂)和补充起始时间(E0、E11、P1)分为九个实验亚组。
- 幼鼠和哺乳母鼠暴露于75%氧气5天(P7-P12),随后返回室内空气5天(P12-P17)。
- 幼鼠在P12和P17被处死,视网膜分析血管无灌注和玻璃体内新生血管。
主要发现
- 与安慰剂相比,补充叶黄素或玉米黄质的孕鼠幼鼠血管无灌注区和玻璃体内新生血管面积显著减少。
- E0或E11起始的产前补充对OIR的保护作用显著优于P1起始的产后补充。
临床怎么用
- 作者建议未来在人类临床试验中测试产前叶黄素和玉米黄质补充以预防ROP。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Premature infants at risk of retinopathy of prematurity (ROP) miss placental transfer of the carotenoids lutein (L) and zeaxanthin (Z) during the third trimester. We previously demonstrated that prenatal L and Z supplementation raised carotenoid levels in infants at birth in the Lutein and Zeaxanthin in Pregnancy (L-ZIP) study (NCT03750968). Based on their antioxidant effects and bioavailability, we hypothesized that prenatal maternal supplementation with macular carotenoids would reduce the risk of ROP. To test this hypothesis, we utilized "macular pigment mice" genetically engineered to take up L and Z into the retina in a model of oxygen-induced retinopathy (OIR). METHODS: Pregnant Bco2-/- mice were divided into nine experimental subgroups based on the type of supplementation (L, Z, or placebo) and on the maternal supplementation start date corresponding to the three trimesters of human fetal development (E0, E11, and P1). Pups and nursing mothers were exposed to 75% O2 for 5 days (P7-P12) and returned to room air for 5 days (P12-P17). Pups were killed at P12 and P17, and their retinas were analyzed for vaso-obliteration and intravitreal neovascularization. RESULTS: Pups of pregnant mice supplemented with L or Z had significant reductions in areas of vaso-obliteration and intravitreal neovascularization compared to placebo. Prenatal carotenoid supplementation starting at E0 or E11 was significantly more protective against OIR than postnatal supplementation starting at P1. CONCLUSIONS: Prenatal supplementation with L and Z was beneficial in a mouse OIR model. We recommend testing prenatal L and Z supplementation in future human clinical trials to prevent ROP.
引用
- Arunkumar R, Li B, Addo EK, et al. Prenatal Carotenoid Supplementation With Lutein or Zeaxanthin Ameliorates Oxygen-Induced Retinopathy (OIR) in Bco2-/- Macular Pigment Mice. Invest Ophthalmol Vis Sci. 2023. PMID: 37036416. doi:10.1167/iovs.64.4.9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。